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A B S T R A C T
Background: Previous studies indicated an association between endothelial nitric oxide synthase (eNOS) activity and 
maintenance of pregnancy, but it is rather controversial whether polymorphisms of the gene encoding for eNOS are associated 
with recurrent spontaneous abortions (RSAs). Aim: The aim was to investigate whether the presence of maternal polymorphism 
Glu298Asp in exon seven of the eNOS gene increase the risk of RSA in Egyptian women. Subjects and Methods: Hundreds 
women were randomly selected as the case group. They had at least three RSA before 20th weeks of gestation, same partner and 
at least one live birth and compared with 100 women, same age range, with no history of abortions or complicated pregnancy 
as control group. All were investigated for the polymorphism using the polymerase chain reaction‑restriction fragment length 
polymorphisms method. Data were expressed descriptively as percentages for qualitative values and mean ± standard deviation 
for quantitative parametric data and comparison of qualitative data was done. Results: Frequency of GG genotype 50/100% in 
cases and 67/100% in control group. Heterozygous GT frequency was 46/100% in cases and 26/100% in control (P ≤ 0.01, odds ratio 
[OR] =2.37, and 95% confidence interval [CI] =1.30–4.34). Homozygous TT was 4/100% in the cases and at 7/100% in control (P = 
0.68, OR = 0.77, and 95% CI = 0.21–2.76). GG genotype versus GT and GG (P = 0.01, OR = 2.03, and 95% CI = 1.15–3.60). Cases with 
TT genotype were more susceptible to abortion at an older age with a mean of 29 (4.76) (P = 0.02). Conclusion: In conclusion, 
(eNOS) Glu298Asp polymorphism was found to be associated with increased risk of RSA in this sample of Egyptian women.
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INTRODUCTION
Recurrent spontaneous abortion (RSA) affects only 5% 
of all couples; it is a most frustrating experience for the 
patient as well as for the clinician. Recently, the spectrum 
of etiologies for RSA has been changing. Some causes 
such as luteal insufficiency and infectious diseases have 
lost much of their previous importance, but some new 
exciting findings have enriched our understanding of 
possible mechanisms of RSA. The sharing of parental 
antigens has become a hot topic again with the finding of 
specific human leukocyte antigen alleles that seem to be 
associated with RSA. Although genetic abnormalities have 
been implicated in recurrent loss of pregnancy for some 
time, skewed X-inactivation was recently found to be an 
additional genetic factor.
During pregnancy, nitric oxide (NO) production in endothelial 
cells increases, probably playing an important role in 
implantation, decidualization, and regulation of blood flow 
in the placenta by means of vasodilatation and myometrial 
relaxation. NO is synthesized by the trophoblast cells, NO 
prevents the contractions of the uterine myometrium directly 
or by an interaction with the cyclooxygenase. NO is also 
apparently crucial for maintenance of the maternal systemic 
vasodilatation and reduced vascular reactivity seen during 
normal pregnancy. It was shown that in the early stage of 
pregnancy, trophoblasts express high amounts of NO synthase 
(NOS) activity, the isoform being endothelial NOS (eNOS). 
Furthermore, placental production of gonadotropic hormone 
is modulated by eNOS expression and the subsequent NO 
release by cytotrophoblast and syncytiotrophoblast cells.[1]
In humans, abnormal NO levels have been shown to 
play a role in hypertension, vasospasm, infraction and 
preeclampsia. Several recent studies were performed to 
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investigate whether polymorphisms of the eNOS gene could 
be risk factors for RSA. An impaired oxygen and nutrient 
supply might affect the ability of the embryo to resist 
maternal rejection in early pregnancy.[2] Among the various 
eNOS gene polymorphisms is Glu298Asp polymorphism 
in exon 7. It is investigated for its potential association 
with RSA in some population. Glu298Asp polymorphism 
alters the stability of the enzyme[3] and is associated with 
various diseases such as myocardial infarction,[4] placental 
abruption, and preeclampsia.[5]
The association between eNOS gene polymorphism and RSA 
has been studied among various ethnic groups, including 
Caucasian, South Indian, North Indian, Chinese, Greek, and 
Taiwanese.[2,6-9] The results of the various studies conflicted 
with each other. Some studies showed positive associations 
between certain genotypes and RSA,[2,6-9] while others did 
not.[2] It has to be stated that the aim of our present study was 
to investigate whether presence of maternal polymorphism 
of the eNOS gene increase the risk of RSA in Egyptian 
women.Thus, we made an effort to reduce an error in the 
interpretation of our result by only considering Egyptian 
women in the study and control groups. Some other studies 
investigating RSA have taken women with no history of live 
births. This strategy does not rule out that RSA might be of 
an anatomical factor, to avoid this possible bias all candidates 
in our study had at least one history of live birth. We also 
took in consideration that our candidates have the same 
partner during their marital life in order to exclude paternal 
chromosomal abnormality that might be a cause of RSA. The 
aim of our study was to investigate whether the presence 
of maternal polymorphism Glu298Asp in exon seven of the 
eNOS gene increase the risk of RSA in Egyptian women.
SUBJECTS AND METHODS
Our study population included 100 women, selected 
by simple random sampling way, with three or more 
RSA before 20 weeks of gestation, with their ages 
ranging (20–35) years as a case group against 100 women 
with no history of spontaneous abortions or complicated 
pregnancy as a control group. All candidates were referred 
from the outpatient clinic of the Prenatal Diagnosis and 
Fetal Medicine Department, National Research Centre 
during the period from June 2010 to May 2011. The study 
was approved by the Scientific and Ethical Committees of 
the National Research Center, Cairo University. An informed 
consent has been obtained from all patients according 
to the National Research Centre Ethical Committee and 
underwent a standard diagnostic workup including: 
Pedigree analysis with detailed medical, obstetric, past 
and family history, serum progesterone, follicle-stimulating 
hormone and luteinizing hormone, TORCH, anticardiolipin 
(IgM and IgG), paternal and maternal karyotyping, and 
abdominal ultrasound.
Collection of samples and isolation of genomic 
DNA
A volume of 5 ml venous blood samples were withdrawn 
from all candidates under complete aseptic conditions 
and collected in a polypropylene tube containing 0.5 M 
ethylenediaminetetraacetic acid (pH 8.0) to prevent clotting 
and nuclease activity and genomic DNA was extracted using 
salting-out method.
Genotype analysis
Polymerase chain reaction (PCR) amplification of DNA samples 
was performed using exon seven of the eNOS gene-specific 
primers (forward [5’-TCCCTGAGGGCATGAGGCT-3¢] and the 
reverse [5’-TGAGGGTCACACAGGTTCCT-3¢.]). PCR products 
were then confirmed by electrophoresis on 2% agarose 
gel. PCR product variants were then digested by specific 
restriction enzymes (Sau3AI enzyme) and analyzed on 2% 
agarose gel stained with Ethidium bromide (7, 25, 26).
Interpretation
The gene coding for eNOS is located on chromosome 
7q35–36 with 26 exons spanning 21 kb. The E/E genotype 
contained 277, 150, and 30 bp SAU3AI fragments reflecting. 
The D/D genotype also contained the 30, 132, 150, and 145 bp 
fragments. Fragment150 and 145 were too close so detected 
as one band). Each of the samples from heterozygotic 
combinations contained both sets of fragments from each 
eNOS allele. E/D 277, 150, and 30 as well as 132 bp fragments 
from cleavage at the SAU3AI site [Figures 1 and 2].
Statistical methods
Data were expressed descriptively as percentages for 
qualitative values and mean ± standard deviation for 
quantitative parametric data. The compiled data were 
computerized and analyzed by SPSS software package, 
version 2, Echosoft Corporation, (Chicago, USA). The 
Figure 1: A 2% agarose gel showing digestion of polymerase chain 
reaction products of exon seven of the endothelial nitric oxide 
synthase gene with SAU3AI for detection of the different genotypes 
in 13 cases. Lanes 1, 2, 6, 7, 8, 10, 11, 13: Eight cases with G/G genotype 
(30, 277, 150 bp). Lane 4: One case subjects with T/T genotype 
(30, 132, 145, 150 bp). Lanes 3, 5, 9, 12: Four cases with G/T genotype 
(30, 132, 145, 150, 277 bp). M: Molecular weight marker (PhiX174 DNA/HaeIII digest) 
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following tests of significance were used: Analysis of 
variance test between more than two means, t-test between 
means was used to analyze mean difference. Comparison of 
qualitative data was done using Chi-square test, crosstabs, 
and least significant difference. A level of significance with P 
≤	0.05	was	considered	significant, P ≤	0.01	was	considered	
of high significance and P > 0.05 insignificant.
RESULTS
Cases population
All patients included in the cases group had three or more 
RSA before 20th weeks of gestation with a range of three to 
10 abortions and the most frequent cases were patients with 
three RSA showing a mode of three, 37/100, (37%) of the cases. 
Their ages ranged from 20 to 35 years, mean 27.32 (4.5).
Control population
All control candidates included in the study group had 
normal live births with no history of spontaneous abortions 
or complicated pregnancy. Their ages ranged from 20 to 35 
years, mean 25.43 (3.78).
Genotypes distribution and allele frequencies 
within groups
The frequency of GG genotype coding for the glu298 isoform 
of eNOS was found to be 50/100 (50%) in cases as compared 
to 67/100 (67%) in control group. The heterozygous genotype 
GT frequencies were 46/100 (46%) in cases and 26/100 (26%) in 
control, (P	≤	0.01,	odds	ratio	[OR]	=2.37,	and	95%	confidence	
interval [CI] =1.30–4.34). Homozygous TT was present at 
a frequency of 4/100 (4%) in the cases and at 7/100 (7%) in 
control, (P = 0.68, OR = 0.77, and 95% CI = 0.21–2.76). GG 
genotype versus GT and TT genotypes with (P = 0.01, OR = 
2.03, and 95% CI = 1.15–3.60) and the frequency of G allele 
was 0.65% for the cases while 0.74% for control group, while 
T allele was 0.35% for the cases and 0.26% for control group. 
With (P = 0.15, OR = 1.47, and 95% CI = 0.87–2.48) [Table 1].
Correlation of the genotypes with age of the 
patient at time of the abortion in the cases 
group (n = 100)
Cases with TT genotype were more susceptible to abortion 
at an older age with the respect to GT and GG genotypes. 
RSA in TT genotype cases had a mean of 29 (4.76) years, 
with a significant (P = 0.02) when compared to GT and GG 
cases with (P = 0.86).
DISCUSSION
The outcome of pregnancy depends to a great extent on the 
success rate of early events, which includes implantation, 
establishment of fetomaternal circulation, and the maintenance 
of increased blood flow to the implantation site. A reduction 
in NO production can lead to impaired placental perfusion and 
a compromised oxygen and nutrient supply to the fetus. In 
humans, abnormal NO levels as well as the polymorphic variants 
have been shown to play an important role in preeclampsia.[6]
The association between eNOS gene polymorphism and 
recurrent spontaneous miscarriage (RSM) has been studied 
among various ethnic groups including Caucasians, South 
Indians, North Indians, Chinese, Greeks, South Koreans, and 
Taiwanese, and the results of the various studies conflicted 
with each other. Some studies showed positive associations 
between certain genotypes and RSM while others did not.
It has to be stated that the aim of our present study was 
to investigate whether presence of maternal polymorphism 
of the eNOS gene increase the risk of RSA in Egyptian 
women. Thus, we made an effort to reduce an error in the 
interpretation of our result by only considering Egyptian 
women in the study and control groups. Some other studies 
investigating RSA have taken women with no history of live 
births. This strategy does not rule out that RSA might be of 
an anatomical factor, to avoid this possible bias all candidates 
in our study had at least one history of live birth. We also 
took into consideration that our candidates have the same 
partner during their marital life in order to exclude paternal 
chromosomal abnormality that might be a cause of RSA.
Our study had shown that the GT genotype coding for the 
Glu298 isoform of eNOS was found to be more associated 
Table 1: Distribution and allele frequencies of eNOS polymorphism 
Glu298Asp in exon 7 among case and control groups
Genotype





OR (95% CI) P*
GG 50 (50.0) 67 (67.0) Reference**
GT 46 (46.0) 26 (26.0) 2.37 (1.30‑4.34) <0.01 (S)
TT 4 (4.0) 7 (7.0) 0.77 (0.21‑2.76) 0.68 (NS)
GG versus GT + TT 50 versus 46+4 67 versus 26+7 2.03 (1.15‑3.60) 0.01 (S)
G 0.66 0.74 Reference***
T 0.34 0.26 1.47 (0.87‑2.48) 0.15 (NS)
*P value is significant at the ≤0.05 level; **The genotype GG was used as a reference in 
calculating the OR and P value of genotypes GG and GT; ***The G allele was used as a reference 
to calculate the OR and P value for the T allele. eNOS=Endothelial nitric oxide synthase, 
OR=Odds ratio, CI=Confidence interval, NS=Nonsignificant, S=Significant
Figure 2: A 2% agarose gel showing digestion of polymerase chain 
reaction products of exon seven of the endothelial nitric oxide 
synthase gene with SAU3AI for detection of the different genotypes in 
12 normal controls. Lanes 1, 5, 6, 8, 9, 10: Five cases with G/T genotype 
(30, 132, 145, 150, 277 bp). Lanes 2, 3, 4, 11, 12: Eight cases with G/G 
genotype (30, 277, 150 bp). Lane 7: One case subjects with T/T genotype 
(30, 132, 145, 150 bp). M: Molecular weight marker (PhiX174 DNA/HaeIII digest) 
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with the increased incidence of RSA as it had a significant 
P value when comparing to other genotypes. RSA cases 
holding TT genotype were more susceptible to abortion at 
an older age with the respect to GT and GG genotypes.
The results of our study are supported with the published 
results of Tempfer et al., 2001, Suryanarayana et al., 2006, 
Shin et al. and Parveen et al., 2011,[6-8,10] and it is opposite to 
Karvela et al., 2008[2] and Pereza et al. 2015.[11]
In another published study, Su et al., 2011 stated that 
angiogenesis and an adequate blood supply are critical for 
several steps in human early pregnancy. Angiogenesis- and 
vasoconstriction-related genes are associated with RSA and 
eNOS is one of these genes.[9]
Our data indicate that the investigated eNOS polymorphism 
confers a small but significantly increased risk of developing 
RSA. However, this polymorphism is not sufficient alone 
to explain the development of RSA, as in some of the 
candidates in the control group had the polymorphism and 
did not complain of RSA. Mechanisms that might explain the 
relationship between eNOS polymorphism and RSA include 
linkage disequilibrium with a mutation within coding 
region or promoter region in eNOS gene, the possibility of 
neighboring gene and altered splicing or processing of the 
primary transcript.
It cannot specify at what level an increase or decrease in 
protein expression regulated by the investigated gene 
could affect the risk of developing RSA. With the respect 
to the eNOS gene, impaired NO production could happen 
at gonadal level, placental level or at the level of the 
placental vasculature. Furthermore, it could be argued 
that evaluating polymorphism only in mother does not 
reflect the pathophysiology process leading to RSA. Ethnic 
variation and genetic admixture need to be considered in 
an evaluation of genetic background of RSA.[12]
CONCLUSION
We were able to find a correlation between the increased 
risk for the occurrence of RSA and polymorphism Glu298Asp 
in eNOS gene exon seven. GT genotype was more significant 
in cases associated with RSA, increasing the risk for RSA by 
2.3 folds. While GG and TT genotypes were insignificant 
in cases of RSA. Cases holding TT genotype are more 
susceptible to abortion at an older age with the respect to GT 
and GG genotype. These results cannot exclude that the TT 
genotypes have not role in the RSA, but additional genetic 
association and functional studies in different populations 
with larger numbers of participants and a uniformly defined 
idiopathic RSA (IRSA) are needed to clarify the contribution 
of NOS3 + 894 G/T gene variation to IRSA.
Molecular genetics diagnosis of the male partner of patients 
diagnosed with RSM in order to define the possible new 
correlation between the incidence of abortion and the 
paternal genotype.
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